Highly sensitive methods based on seminested real-time reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 unspliced and multiply spliced RNA and proviral DNA

Journal of Clinical Microbiology

Volumn 46, Issue 7, 2008, Pages 2206-2211

  Pasternak, Alexander O ^a   Adema, Karen W ^a   Bakker, Margreet ^a   Jurriaans, Suzanne ^a   Berkhout, Ben ^a   Cornelissen, Marion ^a   Lukashov, Vladimir V ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; MOLECULAR MARKER; VIRUS DNA; VIRUS RNA; PRIMER DNA;

ACCURACY; ANALYTIC METHOD; ARTICLE; DRUG TREATMENT FAILURE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROVIRUS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN; BLOOD; EVALUATION; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; MONONUCLEAR CELL; PLASMA; POLYMERASE CHAIN REACTION; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

DNA PRIMERS; DNA, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; PLASMA; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 49049107011     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00055-08     Document Type: Article

References (26)

1. Boom, R., C. J. Sol, M. M. Salimans, C. L. Jansen, P. M. Wertheim-van Dillen, and J. van der Noordaa. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503.
2. Brussel, A., and P. Sonigo. 2003. Analysis of early human immunodeficiency virus type 1 DNA synthesis by use of a new sensitive assay for quantifying integrated provirus. J. Virol. 77:10119-10124.
3. Carrière, M., V. Pène, A. Breiman, F. Conti, S. Chouzenoux, E. Meurs, M. Andrieu, P. Jaffray, L. Grira, O. Soubrane, P. Sogni, Y. Calmus, S. Chaussade, A. R. Rosenberg, and P. Podevin. 2007. A novel, sensitive, and specific RT-PCR technique for quantitation of hepatitis C virus replication. J. Med. Virol. 79:155-160.
4. Chun, T. W., D. C. Nickle, J. S. Justement, D. Large, A. Semerjian, M. E. Curlin, M. A. O'Shea, C. W. Hallahan, M. Daucher, D. J. Ward, S. Moir, J. I. Mullins, C. Kovacs, and A. S. Fauci. 2005. HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir. J. Clin. Investig. 115:3250-3255.
5. del Rio, C. 2006. Current concepts in antiretroviral therapy failure. Top. HIV Med. 14:102-106.
6. de Ronde, A., M. van Dooren, L. van Der Hoek, D. Bouwhuis, E. de Rooij, B. van Gemen, R. de Boer, and J. Goudsmit. 2001. Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus. J. Virol. 75:595-602.
7. + T cells. Nature 417:95-98.
8. Espy, M. J., J. R. Uhl, L. M. Sloan, S. P. Buckwalter, M. F. Jones, E. A. Vetter, J. D. C. Yao, N. L. Wengenack, J. E. Rosenblatt, F. R. Cockerill III, and T. F. Smith. 2006. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin. Microbiol. Rev. 19:165-256.
9. Fischer, M., B. Joos, B. Hirschel, G. Bleiber, R. Weber, H. F. Günthard, et al. 2004. Cellular viral rebound after cessation of potent antiretroviral therapy predicted by levels of multiply spliced HIV-1 RNA encoding nef. J. Infect. Dis. 190:1979-1988.
10. Fischer, M., J. K. Wong, D. Russenberger, B. Joos, M. Opravil, B. Hirschel, A. Trkola, H. Kuster, R. Weber, H. F. Günthard, et al. 2002. Residual cell-associated unspliced HIV-1 RNA in peripheral blood of patients on potent antiretroviral therapy represents intracellular transcripts. Antivir. Ther. 7:91-103.
11. Frenkel, L. M., Y. Wang, G. H. Learn, J. L. McKernan, G. M. Ellis, K. M. Mohan, S. E. Holte, S. M. De Vange, D. M. Pawluk, A. J. Melvin, P. F. Lewis, L. M. Heath, I. A. Beck, M. Mahalanabis, W. E. Naugler, N. H. Tobin, and J. I. Mullins. 2003. Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy. J. Virol. 77:5721-5730.
12. Halliday, C., Q. X. Wu, G. James, and T. Sorrell. 2005. Development of a nested qualitative real-time PCR assay to detect Aspergillus species DNA in clinical specimens. J. Clin. Microbiol. 43:5366-5368.
13. Havlir, D. V., M. C. Strain, M. Clerici, C. Ignacio, D. Trabattoni, P. Ferrante, and J. K. Wong. 2003. Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years. J. Virol. 77:11212-11219.
14. + T lymphocytes in vivo. J. Virol. 77:7383-7392.
15. Jackson, J. B., C. Ndugwa, F. Mmiro, P. Kataaha, L. Guay, E. A. Dragon, J. Goldfarb, and K. Olness. 1991. Non-isotopic polymerase chain reaction methods for the detection of HIV-1 in Ugandan mothers and infants. AIDS 5:1463-1467.
16. Jiang, S. S., T. C. Chen, J. Y. Yang, C. A. Hsiung, I. J. Su, Y. L. Liu, P. C. Chen, and J. L. Juang. 2004. Sensitive and quantitative detection of severe acute respiratory syndrome coronavirus infection by real-time nested polymerase chain reaction. Clin. Infect. Dis. 38:293-296.
17. Max, N., K. Wolf, E. Thiel, and U. Keilholz. 2002. Quantitative nested real-time RT-PCR specific for tyrosinase transcripts to quantitate minimal residual disease. Clin. Chim. Acta 317:39-46.
18. Petitjean, G., Y. Al Tabaa, E. Tuaillon, C. Mettling, V. Baillat, J. Reynes, M. Segondy, and J. Vendrell. 2007. Unintegrated HIV-1 provides an inducible and functional reservoir in untreated and highly active antiretroviral therapy-treated patients. Retrovirology 4:60.
19. Ramratnam, B., R. Ribeiro, T. He, C. Chung, V. Simon, J. Vanderhoeven, A. Hurley, L. Zhang, A. S. Perelson, D. D. Ho, and M. Markowitz. 2004. Intensification of antiretroviral therapy accelerates the decay of the HIV-1 latent reservoir and decreases, but does not eliminate, ongoing virus replication. J. Acquir. Immune Defic. Syndr. 35:33-37.
20. + T cells. Nat. Med. 9:727-728.
21. Sonza, S., H. P. Mutimer, K. O'Brien, P. Ellery, J. L. Howard, J. H. Axelrod, N. J. Deacon, S. M. Crowe, and D. F. Purcell. 2002. Selectively reduced tat mRNA heralds the decline in productive human immunodeficiency virus type 1 infection in monocyte-derived macrophages. J. Virol. 76:12611-12621.
22. Takahashi, T., and T. Nakayama. 2006. Novel technique of quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA. J. Clin. Microbiol. 44:1029-1039.
23. Tobin, N. H., G. H. Learn, S. E. Holte, Y. Wang, A. J. Melvin, J. L. Mc-Kernan, D. M. Pawluk, K. M. Mohan, P. F. Lewis, J. I. Mullins, and L. M. Frenkel. 2005. Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus. J. Virol. 279:9625-9634.
24. van Doornum, G. J., M. Schutten, J. Voermans, G. J. Guldemeester, and H. G. Niesters. 2007. Development and implementation of real-time nucleic acid amplification for the detection of enterovirus infections in comparison to rapid culture of various clinical specimens. J. Med. Virol. 79:1868-1876.
25. Vesanen, M., M. Markowitz, Y. Cao, D. D. Ho, and K. Saksela. 1997. Human immunodeficiency virus type1 mRNA splicing pattern in infected persons is determined by the proportion of newly infected cells. Virology 236:104-109.
26. Yamamoto, N., C. Tanaka, Y. Wu, M. O. Chang, Y. Inagaki, Y. Saito, T. Naito, H. Ogasawara, I. Sekigawa, and Y. Hayashida. 2006. Analysis of human immunodeficiency virus type 1 integration by using a specific, sensitive and quantitative assay based on real-time polymerase chain reaction. Virus Genes 32:105-113.